epigenetics

February 16, 2022

Yale surgery chair to discuss cancer’s ‘on’ switch at next Discovery Lecture

Renowned surgical oncologist and clinician scientist Nita Ahuja, MD, MBA, chair of the Department of Surgery at Yale School of Medicine, will deliver the next web-based Discovery Lecture.

By Leigh MacMillan
February 6, 2020

New tool probes gene regulation

Vanderbilt biochemists got unexpected results when they used their new approach to explore the role of DNA methylation in gene regulation.

By Leigh MacMillan
March 14, 2019

New way to stimulate learning?

Vagus nerve stimulation could be beneficial for treating Alzheimer’s disease and other forms of cognitive impairment, Vanderbilt research findings suggest.

By Bill Snyder
(iStock)
January 17, 2019

Building a pancreas

Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes.

By Leigh MacMillan
November 1, 2018

Cancer epigenetics expert Baylin set for Discovery Lecture

Stephen Baylin, MD, a trailblazer in the study of the epigenetics of cancer, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 8. His lecture, sponsored by the Vanderbilt-Ingram Cancer Center, will begin at 4 p.m. in room 208 Light Hall.

By Bill Snyder
April 11, 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

By Bill Snyder
November 2, 2017

Sweatt, Tansey discuss influence of epigenetics on research

Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks.
By Bill Snyder
August 31, 2017

Epigenetics expert Allis set for Sept. 7 Discovery Lecture

Internationally known epigeneticist C. David Allis, Ph.D., will deliver the first Flexner Discovery Lecture of the academic year at 4 p.m. Thursday, Sept. 7, in room 208 Light Hall.
By Bill Snyder
July 24, 2017

How Epo action is ‘enhanced’

The hormone erythropoietin (Epo) controls red blood cell production and synthetic forms of Epo treat multiple disorders. New Vanderbilt research details how Epo works.
By Bill Snyder
May 11, 2017

Top cancer researchers reveal latest findings at VICC science retreat

Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer.
By VUMC News and Communications
March 16, 2017

Esophageal cancer complexities

New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers.
By VUMC News and Communications
January 24, 2017

Saliva test for obesity risk

“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.
By Bill Snyder
January 9, 2014

Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.
By Bill Snyder